MoU Or Statutory Fix? FDA/CMS “Harmonization” Strategies Are Under Review
This article was originally published in The Gray Sheet
Executive Summary
FDA and CMS will likely produce a memorandum of understanding soon after the HHS Secretary's Advisory Panel on Regulatory Reform holds its final meeting Oct. 1-2 in Washington, D.C
You may also be interested in...
Department-Wide Task Force Sets Nov. 8 Agenda For Med Tech Innovation
HHS' task force on stimulating innovation in medical technologies will convene in Washington, D.C. Nov. 8 to review 12-15 "promising ideas" gleaned from stakeholder comments this summer
Department-Wide Task Force Sets Nov. 8 Agenda For Med Tech Innovation
HHS' task force on stimulating innovation in medical technologies will convene in Washington, D.C. Nov. 8 to review 12-15 "promising ideas" gleaned from stakeholder comments this summer
Six Months Sufficient For CMS In-House NCDs – HHS Reg Reform Panel
CMS should impose a six-month timeframe for all in-house national coverage determinations (NCDs) for new technology items, the HHS Secretary's Advisory Committee on Regulatory Reform final report recommends